203 related articles for article (PubMed ID: 24258990)
1. Clinical, pathologic, and imaging features and biological markers of uveal melanoma.
Rashid AB; Grossniklaus HE
Methods Mol Biol; 2014; 1102():397-425. PubMed ID: 24258990
[TBL] [Abstract][Full Text] [Related]
2. [Prospects for developing treatment of uveal melanoma from the position of modern carcinogenesis concepts].
Likhvantseva VG
Vestn Oftalmol; 2002; 118(1):32-5. PubMed ID: 11898358
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target.
All-Ericsson C; Girnita L; Seregard S; Bartolazzi A; Jager MJ; Larsson O
Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):1-8. PubMed ID: 11773005
[TBL] [Abstract][Full Text] [Related]
4. Melanocortin 1 receptor is expressed by uveal malignant melanoma and can be considered a new target for diagnosis and immunotherapy.
López MN; Pereda C; Ramírez M; Mendoza-Naranjo A; Serrano A; Ferreira A; Poblete R; Kalergis AM; Kiessling R; Salazar-Onfray F
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1219-27. PubMed ID: 17325166
[TBL] [Abstract][Full Text] [Related]
5. Histopathologic, immunohistochemical, and cytogenetic analysis of primary clear cell melanoma of the uvea.
Verdijk RM; Koopmans AE; Kilic E; Paridaens D; de Klein A
JAMA Ophthalmol; 2013 Jun; 131(6):814-6. PubMed ID: 23579462
[No Abstract] [Full Text] [Related]
6. [Two cases of bilateral uveal melanoma].
Saakian SV; Iurovskaia NN; Miakoshina EB
Vestn Oftalmol; 2011; 127(3):31-6. PubMed ID: 21800723
[TBL] [Abstract][Full Text] [Related]
7. Circulating tumor cells in uveal melanoma.
Torres V; Triozzi P; Eng C; Tubbs R; Schoenfiled L; Crabb JW; Saunthararajah Y; Singh AD
Future Oncol; 2011 Jan; 7(1):101-9. PubMed ID: 21174541
[TBL] [Abstract][Full Text] [Related]
8. Uveal melanoma: diagnostic features.
Biscotti CV; Singh AD
Monogr Clin Cytol; 2012; 21():44-54. PubMed ID: 22024583
[No Abstract] [Full Text] [Related]
9. Cripto-1 expression in uveal melanoma: an immunohistochemical study.
Mallikarjuna K; Vaijayanthi P; Krishnakumar S
Exp Eye Res; 2007 Jun; 84(6):1060-6. PubMed ID: 17412323
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical assessment of mitotic count in uveal melanoma.
Angi M; Damato B; Kalirai H; Dodson A; Taktak A; Coupland SE
Acta Ophthalmol; 2011 Mar; 89(2):e155-60. PubMed ID: 19900200
[TBL] [Abstract][Full Text] [Related]
11. Expression and distribution of MMPs and TIMPs in human uveal melanoma.
Lai K; Conway RM; Crouch R; Jager MJ; Madigan MC
Exp Eye Res; 2008 Jun; 86(6):936-41. PubMed ID: 18423620
[TBL] [Abstract][Full Text] [Related]
12. CXC chemokine receptor 4 is expressed in uveal malignant melanoma and correlates with the epithelioid-mixed cell type.
Scala S; Ieranò C; Ottaiano A; Franco R; La Mura A; Liguori G; Mascolo M; Staibano S; Ascierto PA; Botti G; De Rosa G; Castello G
Cancer Immunol Immunother; 2007 Oct; 56(10):1589-95. PubMed ID: 17410362
[TBL] [Abstract][Full Text] [Related]
13. Uveal MALT lymphoma with extensive AL-type amyloid production mimicking uveal melanoma.
Haq I; Rundle PA; Gilbertson JA; Wechalekar AD; Mudhar HS
Histopathology; 2015 Mar; 66(4):607-10. PubMed ID: 24853590
[No Abstract] [Full Text] [Related]
14. Whole-body bioluminescent imaging of human uveal melanoma in a new mouse model of local tumor growth and metastasis.
Notting IC; Buijs JT; Que I; Mintardjo RE; van der Horst G; Karperien M; Missotten GS; Jager MJ; Schalij-Delfos NE; Keunen JE; van der Pluijm G
Invest Ophthalmol Vis Sci; 2005 May; 46(5):1581-7. PubMed ID: 15851554
[TBL] [Abstract][Full Text] [Related]
15. [Study of a role of the expression of a transmembranous CD117/C-Kit receptor in the progression of uveal melanomas].
Anurova OA; Likhvantseva VG; Vereshchagina MV
Vestn Oftalmol; 2007; 123(5):41-4. PubMed ID: 18078058
[TBL] [Abstract][Full Text] [Related]
16. Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma.
Blom DJ; Luyten GP; Mooy C; Kerkvliet S; Zwinderman AH; Jager MJ
Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1865-72. PubMed ID: 9286277
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of fourteen proteins between uveal melanoma from patients who subsequently developed distant metastases versus those who did Not.
Linge A; Kennedy S; O'Flynn D; Beatty S; Moriarty P; Henry M; Clynes M; Larkin A; Meleady P
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4634-43. PubMed ID: 22570344
[TBL] [Abstract][Full Text] [Related]
18. c-MET expression in primary and liver metastases in uveal melanoma.
Gardner FP; Serie DJ; Salomao DR; Wu KJ; Markovic SN; Pulido JS; Joseph RW
Melanoma Res; 2014 Dec; 24(6):617-20. PubMed ID: 25211165
[TBL] [Abstract][Full Text] [Related]
19. A critical appraisal of the prognostic and predictive factors for uveal malignant melanoma.
Mudhar HS; Parsons MA; Sisley K; Rundle P; Singh A; Rennie IG
Histopathology; 2004 Jul; 45(1):1-12. PubMed ID: 15228438
[No Abstract] [Full Text] [Related]
20. Carcinoembryonic antigen cell adhesion molecule-1 (CEACAM1) in posterior uveal melanoma: correlation with clinical and histological survival markers.
Khatib N; Pe'er J; Ortenberg R; Schachter J; Frenkel S; Markel G; Amer R
Invest Ophthalmol Vis Sci; 2011 Dec; 52(13):9368-72. PubMed ID: 22039239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
